MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Intermediaries
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
Massachusetts
*Triple Helix Cluster & Developments: Massachusetts
*Industry: Massachusetts
Celldex Therapeutics, Inc (NASDAQ: CLDX)
Organization & Developments: Celldex
Parents
Celldex Therapeutics, Inc (NASDAQ: CLDX)
Children
*Biopharmaceutical company focused on development and commercialization of immunotherapy technologies for the treatment of cancer and other diseases.
*Monoclonal antibodies focus the body’s immunological response specifically against a target cancer cell, and have been used in several approved oncology drugs, including Bristol-Myers Squibb's Herceptin for breast cancer.
2013: Celldex stock jumps 20 percent on strong cancer drug data (2013)
2014: Celldex, Bristol-Myers Cut Deal on Immuno-Oncology Combo Trial
2016: Celldex Set To Bounce Back - Celldex Therapeutics, Inc (NASDAQ:CLDX)
2016: Downgrades: 3 Things You Must Know About the Crash at Celldex Therapeutics
2018: Celldex to ax 20% of staff after midstage glembatumumab rout
2018: Celldex Tumbles On Phase 2 Trial Failure; Is There Any Value Left? - Celldex Therapeutics, Inc (NASDAQ:CLDX)
2019: Catalyst in Focus: Celldex Therapeutics_seekingalpha.com
2020: Celldex Jumps On CDX-0159 Data
2020: Why Celldex Has Been A Big Winner In 202
2023: Celldex: Mast Cell Disease Targeting Continues To Make Advancements In Clinic
2024: Celldex Therapeutics' Strong Cash Runway Supports Barzolvolimab's Path To Market
2025: Celldex: Despite Dropping Eosinophilic Esophagitis Program, Barzolvolimab On Track
Jumps
*Key People: Celldex
Finance & Acquisitions: Celldex